Reporting clinical research: Guidance to encourage accurate and transparent research reporting

Maturitas

Volumn 72, Issue 1, 2012, Pages 84-87

  Simera, Iveta ^a   Kirtley, Shona ^a   Altman, Douglas G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Accurate; Guidance; Research reporting; Transparent

Indexed keywords

CLINICAL RESEARCH; EPIDEMIOLOGY; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; SHORT SURVEY; SYSTEMATIC REVIEW (TOPIC);

BIOMEDICAL RESEARCH; GUIDELINES AS TOPIC; HUMANS; INTERNET; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH REPORT;

EID: 84859534969     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.02.012     Document Type: Short Survey

References (34)

1. European Science Foundation. Implementation of medical research in clinical practice: an ESF forward look, 2011. Available at: http://www.esf.org/ index.php?eID=tx ccdamdl file&p[file=33492&p[dl]=1&p[pid]= 3728&p[site]=European%20Science%20Foundation&p[t]=1328783286&hash= d98eb5ffc883f98118669892692e1c3e&l=en] (accessed 2.02.12).
2. Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG. Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med 2010;8:24.
3. EQUATOR Network Library for Health Research Reporting. Available at: http://www.equator-network.org/resource-centre/library-of-healthresearch- reporting/ (accessed 31.01.12).
4. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
5. CONSORT Statement website. Available at: http://www.consort-statement.org (accessed 31.01.12).
6. Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010;340:c723.
7. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLoS Med 2007;4(10):e296.
8. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4(10):e297.
9. Little J, Higgins JP, Ioannidis JP, et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009;6(2):e22.
10. Gallo V, Egger M, McCormack V, et al. STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBEME): an extension of the STROBE statement. Eur J Clin Invest 2012;42(1):1-16.
11. STROBE Statement website. Draft checklist for abstracts. http://www.strobestatement.org/index.php?id=available-checklists (accessed 02.02.12).
12. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007;4:e78.
13. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(9193):1896- 900.
14. Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 2009;6(7):e1000097.
15. Song F, Parekh S, Hooper L, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010;4(8):1-193, iii, ix-xi.
16. Tam VC, Tannock IF, Massey C, Rauw J, Krzyzanowska MK. Compendium of unpublished phase III trials in oncology: characteristics and impact on clinical practice. J Clin Oncol 2011;29(23):3133-9.
17. Ioannidis JP, Manzoli L, De Vito C, D'Addario M, Villari P. Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination. PLoS One 2011;6(12):e28346.
18. Blümle A, Meerpohl JJ, Rücker G, Antes G, Schumacher M, von Elm E. Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles. BMJ 2011;342:d1828.
19. Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS One 2010;5(3):e9810.
20. Dwan K, Altman DG, Cresswell L, Blundell M, Gamble CL, Williamson PR. Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev 2011;(1). MR000031.
21. Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ 2008;336:1472-4.
22. Dijkers M, Kropp GC, Esper RM, Yavuzer G, Cullen N, Bakdalieh Y. Quality of intervention research reporting in medical rehabilitation journals. Am J Phys Med Rehabil 2002;81(1):21-33. (Pubitemid 34027957)
23. Toulmonde M, Bellera C, Mathoulin-Pelissier S, Debled M, Bui B, Italiano A. Quality of randomized controlled trials reporting in the treatment of sarcomas. J Clin Oncol 2011;29(9):1204-9.
24. Abdul Latif L, Daud Amadera JE, Pimentel D, Pimentel T, Fregni F. Sample size calculation in physical medicine and rehabilitation: a systematic review of reporting, characteristics, and results in randomized controlled trials. Arch Phys Med Rehabil 2011;92(2):306-15.
25. Mackinnon A. The use and reporting of multiple imputation in medical research - A review. J Intern Med 2010;268(6):586-93.
26. Parsons NR, Hiskens R, Price CL, Achten J, Costa ML. A systematic survey of the quality of research reporting in general orthopaedic journals. J Bone Joint Surg Br 2011;93(9):1154-9.
27. Kirkham JJ, Dwan KM, Altman DG, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365.
28. Dwan KM, Altman DG, Arnaiz JA, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008;3:e3081.
29. Chowers MY, Gottesman BS, Leibovici L, Pielmeier U, Andreassen S, Paul M. Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review. J Antimicrob Chemother 2009;64:239-50.
30. Breau RH, Gaboury I, Scales Jr CD, Fesperman SF, Watterson JD, Dahm P. Reporting of harm in randomized controlled trials published in the urological literature. J Urol 2010;183(5):1693-7.
31. Gigerenzer G, Wegwarth O, Feufel M. Misleading communication of risk. BMJ 2010;341:c4830.
32. Siontis GC, Patsopoulos NA, Vlahos AP, Ioannidis JP. Selection and presentation of imaging figures in the medical literature. PLoS One 2010;5(5):e10888.
33. Mathieu S, Giraudeau B, Soubrier M, Ravaud P. Misleading abstract conclusions in randomized controlled trials in rheumatology: comparison of the abstract conclusions and the results section. Joint Bone Spine 2011 [Epub ahead of print].
34. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303(20):2058-64.